| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | methylstat | CTRPv2 | pan-cancer | AAC | 0.0029 | 0.9 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.0026 | 0.9 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | 0.002 | 0.9 |
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | -0.0024 | 0.9 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | -0.0049 | 1 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.0027 | 1 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | 0.0023 | 1 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | BMS-708163 | GDSC1000 | pan-cancer | AAC | 0.002 | 1 |